Our Mission Assistance Case Studies Press Room IPAO Forum
HOME : Emory Case Study : Emory Case Study : Emory Case Study
< Previous Next >
Suppes Case Study

Townsend Case Study

Kaswan Case Study

Badylak Case Study

Emory Case Study



Táborský Case Study

Awards/Legal Rulings

After six years of legal debate involving upwards of 40 attorneys at one point in the trial, the lawsuit and counterclaim were settled out of court. As a result:

  • Emory and Triangle Pharmaceuticals were granted exclusive worldwide rights for the test data and intellectual property related to FTC. Emory retained the rights to both 3TC and FTC, thereby securing the intellectual property of their inventors they had sought all along to protect.
  • Glaxo and Shire obtained exclusive license from Emory to 3TC.
  • Triangle Pharmaceuticals was able to keep its license to FTC, which is now commercialized by Gilead Sciences as a result of their purchase of Triangle.
  • Glaxo received an undisclosed payment from Emory and Triangle.

Pertinent Documents

None of the case filings related to this case are accessible and the parties involved kept the settlement of the dispute confidential.

Also of Interest...

University Resolves Dispute on Stem Cell Patent License

Who Owns Good Ideas?

Anti-Cancer Vaccine Technology & Researchers Defended by University

 
< Previous Next >
 
 
IP Advocate.org Copyright 2019
                 
 
 
 


You are about to leave IPAdvocate.org and go to an outside website.

IPAdvocate.org does not control any outside website and is not responsible

for content, performance or policies, including Privacy Policy.

Thank you for visiting IPAdvocate.org.